Patent ID: 6608088
Filing Date: 2003-08-19
Classification: A61K,A61P

Abstract:
A method of treating pain, functional pain syndromes, or organic pain syndromes in a patient comprising administering a pharmaceutically effective amount of an acetylcholinesterase inhibitor with high specificity and selectivity for centrally active acetylcholinesterase to a patient in need thereof wherein the acetylcholinesterase inhibitor is Donepezil or a pharmaceutically acceptable salt thereof, andwherein the pain, functional pain syndromes, or organic pain syndromes are selected from the group consisting of migraine, primary fibromyalgia, and pain syndromes due to amputation (â€œphantom limbâ€ ); and the pain results from tumoral denervation, traumatic denervation, or autoimmune mechanism.